Lumena Pharmaceuticals
develops treatment and products for cholestatic liver diseases and metabolic disorders... Read moreLumena Pharmaceuticals
develops treatment and products for cholestatic liver diseases and metabolic disorders... Read more
CEO
Add
News
May 29, 2014
BUSINESS WIRE
Press Release: Lumena Pharmaceuticals : Research and Markets: Primary Sclerosing Cholangitis Therapeutics Pipeline Review 2014
May 13, 2014
DEAL FEED INTERNATIONAL
Lumena Pharmaceuticals: Shire Plc acquires Lumena Pharmaceuticals
May 13, 2014
BIRMINGHAM STAR
Lumena Pharmaceuticals: Lumena bought for $260 million
May 13, 2014
ZIMBABWE STAR
Lumena Pharmaceuticals: Lumena bought for $260 million
May 13, 2014
REUTERS
Lumena Pharmaceuticals: UPDATE 1-Shire buys Lumena Pharma for at least $260 mln
May 12, 2014
SAN DIEGO BUSINESS JOURNAL
Lumena Pharmaceuticals: Lumena Acquired by Shire for $260 Million
May 12, 2014
BUSINESS WIRE
Press Release: Lumena Pharmaceuticals : RiverVest Venture Partners’ Portfolio Company Lumena is Sold to Shire for $260 million; Represents Sixth Exit from RiverVest Venture Fund II
May 12, 2014
TRIANGLE BUSINESS JOURNAL
Lumena Pharmaceuticals: Pappas Ventures stands to gain in $260M pharma acquisition
May 12, 2014
REUTERS
Lumena Pharmaceuticals: Shire buys Lumena Pharma for at least $260 mln
May 09, 2014
BIOSPACE
Lumena Pharmaceuticals: Lumena Pharmaceuticals Now Dosing Patients In The INDIGO Phase 2 Clinical Trial Of LUM001 In Pediatric Patients With Progressive Familial Intrahepatic Cholestasis
Lumena Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10